This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Neuronova Ab. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Anders Haegerstrand - Innovator in Medical Applications
Introduction
Anders Haegerstrand is an inventor based in Stockholm, Sweden. He is associated with Annexin Pharmaceuticals AB, where he contributes to the development of innovative medical solutions. Although he currently holds no granted patents, his work focuses on significant advancements in the treatment of eye-related conditions.
Latest Patent Applications
Anders Haegerstrand's notable patent application is titled "Monomeric Annexin A5 for Use in the Treatment of Macular Oedema or Retinal Vein Occlusion." This invention relates to novel methods, uses, and compositions of a molecule consisting of monomeric Annexin A5 protein. It aims for the prophylaxis or treatment of macular oedema and associated diseases, disorders, or conditions. In a preferred embodiment, the Annexin A5 is administered systemically, such as intravenously.
Conclusion
Anders Haegerstrand is a dedicated inventor whose work in medical applications holds promise for improving treatments for macular oedema and related conditions. His innovative approach reflects the ongoing efforts in the field of medical research and development.